• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类有机阴离子转运蛋白1中底物结合及脂质介导的变构效应的原子尺度研究

Substrate binding and lipid-mediated allostery in the human organic anion transporter 1 at the atomic-scale.

作者信息

Janaszkiewicz Angelika, Tóth Ágota, Faucher Quentin, Arnion Hélène, Védrenne Nicolas, Barin-Le Guellec Chantal, Marquet Pierre, Di Meo Florent

机构信息

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France.

Inserm U1248 Pharmacology & Transplantation, Univ. Limoges, 87000 Limoges, France; Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utre-cht University, 3584 CG Utrecht, The Netherlands.

出版信息

Biomed Pharmacother. 2023 Apr;160:114342. doi: 10.1016/j.biopha.2023.114342. Epub 2023 Feb 3.

DOI:10.1016/j.biopha.2023.114342
PMID:36739760
Abstract

The Organic Anion Transporter 1 is a membrane transporter known for its central role in drug elimination by the kidney. hOAT1 is an antiporter translocating substrate in exchange for a-ketoglutarate. The understanding of hOAT1 structure and function remains limited due to the absence of resolved structure of hOAT1. Benefiting from conserved structural and functional patterns shared with other Major Facilitator Superfamily transporters, the present study intended to investigate fragments of hOAT1 transport function and modulation of its activity in order to make a step forward the understanding of its transport cycle. μs-long molecular dynamics simulation of hOAT1 were carried out suggesting two plausible binding sites for a typical substrate, adefovir, in line with experimental observations. The well-known B-like motif binding site was observed in line with previous studies. However, we here propose a new inner binding cavity which is expected to be involved in substrate translocation event. Binding modes of hOAT1 co-substrate α-ketoglutarate were also investigated suggesting that it may bind to highly conserved intracellular motifs. We here hypothesise that α-ketoglutarate may disrupt the pseudo-symmetrical intracellular charge-relay system which in turn may participate to the destabilisation of OF conformation. Investigations regarding allosteric communications along hOAT1 also suggest that substrate binding event might modulate the dynamics of intracellular charge relay system, assisted by surrounding lipids as active partners. We here proposed a structural rationalisation of transport impairments observed for two single nucleotide polymorphisms, p.Arg50His and p.Arg454Gln suggesting that the present model may be used to transport dysfunctions arising from hOAT1 mutations.

摘要

有机阴离子转运体1是一种膜转运蛋白,因其在肾脏药物消除中的核心作用而闻名。人有机阴离子转运体1(hOAT1)是一种反向转运体,它转运底物以交换α-酮戊二酸。由于缺乏hOAT1的解析结构,对其结构和功能的理解仍然有限。受益于与其他主要易化子超家族转运蛋白共有的保守结构和功能模式,本研究旨在研究hOAT1转运功能的片段及其活性调节,以便在理解其转运循环方面取得进展。对hOAT1进行了微秒级的分子动力学模拟,结果表明一种典型底物阿德福韦有两个可能的结合位点,这与实验观察结果一致。与先前的研究一致,观察到了著名的B样基序结合位点。然而,我们在此提出了一个新的内部结合腔,预计它参与底物转运事件。还研究了hOAT1共底物α-酮戊二酸的结合模式,表明它可能与高度保守的细胞内基序结合。我们在此假设,α-酮戊二酸可能破坏假对称的细胞内电荷中继系统,这反过来可能参与OF构象的不稳定。对hOAT1上的变构通讯的研究还表明,底物结合事件可能会调节细胞内电荷中继系统的动力学,周围脂质作为活性伙伴起到辅助作用。我们在此提出了对两种单核苷酸多态性p.Arg50His和p.Arg454Gln所观察到的转运损伤的结构合理化解释,表明当前模型可用于解释由hOAT1突变引起的转运功能障碍。

相似文献

1
Substrate binding and lipid-mediated allostery in the human organic anion transporter 1 at the atomic-scale.人类有机阴离子转运蛋白1中底物结合及脂质介导的变构效应的原子尺度研究
Biomed Pharmacother. 2023 Apr;160:114342. doi: 10.1016/j.biopha.2023.114342. Epub 2023 Feb 3.
2
Insights into the structure and function of the human organic anion transporter 1 in lipid bilayer membranes.人有机阴离子转运蛋白 1 在脂质双层膜中的结构与功能的研究进展。
Sci Rep. 2022 Apr 29;12(1):7057. doi: 10.1038/s41598-022-10755-2.
3
A three-dimensional model of human organic anion transporter 1: aromatic amino acids required for substrate transport.人有机阴离子转运体1的三维模型:底物转运所需的芳香族氨基酸
J Biol Chem. 2006 Dec 8;281(49):38071-9. doi: 10.1074/jbc.M608834200. Epub 2006 Oct 11.
4
Critical amino acid residues in transmembrane domain 1 of the human organic anion transporter hOAT1.人类有机阴离子转运体hOAT1跨膜结构域1中的关键氨基酸残基。
J Biol Chem. 2004 Jul 23;279(30):31478-82. doi: 10.1074/jbc.M404686200. Epub 2004 May 15.
5
Interactions with selected drug renal transporters and transporter-mediated cytotoxicity in antiviral agents from the group of acyclic nucleoside phosphonates.无环核苷膦酸类抗病毒药物与选定的药物肾转运体的相互作用及转运体介导的细胞毒性。
Toxicology. 2013 Sep 15;311(3):135-46. doi: 10.1016/j.tox.2013.07.004. Epub 2013 Jul 13.
6
Renal secretion of hydrochlorothiazide involves organic anion transporter 1/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K.氢氯噻嗪的肾分泌涉及有机阴离子转运蛋白 1/3、有机阳离子转运蛋白 2 和多药和毒素外排蛋白 2-K。
Am J Physiol Renal Physiol. 2019 Oct 1;317(4):F805-F814. doi: 10.1152/ajprenal.00141.2019. Epub 2019 Jul 19.
7
Cl- -dependent upregulation of human organic anion transporters: different effects on transport kinetics between hOAT1 and hOAT3.氯离子依赖性上调人有机阴离子转运体:hOAT1和hOAT3对转运动力学的不同影响。
Am J Physiol Renal Physiol. 2007 Jul;293(1):F391-7. doi: 10.1152/ajprenal.00376.2006. Epub 2007 Apr 11.
8
Functional consequences of single nucleotide polymorphisms in the human organic anion transporter hOAT1 (SLC22A6).人类有机阴离子转运体hOAT1(SLC22A6)单核苷酸多态性的功能后果
J Pharmacol Exp Ther. 2005 Aug;314(2):923-31. doi: 10.1124/jpet.105.084301. Epub 2005 May 24.
9
Andrographolide is neither a human organic anion transporter 1 (hOAT1) substrate nor inhibitor.穿心莲内酯既不是人有机阴离子转运体1(hOAT1)的底物,也不是其抑制剂。
J Asian Nat Prod Res. 2019 Aug;21(8):754-771. doi: 10.1080/10286020.2018.1520704. Epub 2019 Jan 3.
10
The role of Nedd4-1 WW domains in binding and regulating human organic anion transporter 1.Nedd4-1 WW 结构域在结合和调节人类有机阴离子转运体1中的作用。
Am J Physiol Renal Physiol. 2016 Aug 1;311(2):F320-9. doi: 10.1152/ajprenal.00153.2016. Epub 2016 May 25.

引用本文的文献

1
Energetic and structural control of polyspecificity in a multidrug transporter.多药转运蛋白中多特异性的能量和结构控制
bioRxiv. 2025 Apr 10:2025.04.09.647630. doi: 10.1101/2025.04.09.647630.
2
Membrane-dependent dynamics and dual translocation mechanisms of ABCB4: Insights from molecular dynamics simulations.ABCB4的膜依赖性动力学和双重转运机制:来自分子动力学模拟的见解
Comput Struct Biotechnol J. 2025 Mar 6;27:1215-1232. doi: 10.1016/j.csbj.2025.03.004. eCollection 2025.
3
ATP-Binding Cassette and Solute Carrier Transporters: Understanding Their Mechanisms and Drug Modulation Through Structural and Modeling Approaches.
ATP结合盒转运体与溶质载体转运体:通过结构和建模方法理解其机制及药物调控
Pharmaceuticals (Basel). 2024 Nov 27;17(12):1602. doi: 10.3390/ph17121602.
4
In silico prediction of the interaction of legacy and novel per- and poly-fluoroalkyl substances (PFAS) with selected human transporters and of their possible accumulation in the human body.基于计算机的预测,评估新型和传统全氟及多氟烷基物质(PFAS)与选定人体转运蛋白的相互作用,并预测它们在人体内的可能积累情况。
Arch Toxicol. 2024 Sep;98(9):3035-3047. doi: 10.1007/s00204-024-03797-0. Epub 2024 Jun 17.